Company Overview - Protagonist Therapeutics focuses on innovation through novel peptides, specializing in both injectable and oral peptides, with a history dating back to 2008 [3] - The company went public in 2016, with Barclays as one of the banks that facilitated the IPO [2] Recent Developments - Protagonist has two significant assets that demonstrated outstanding Phase III data last year, indicating progress in their clinical development [4]